(MENAFN- GetNews)


"prominent players in the patient monitoring market are Medtronic (Ireland), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), GE Healthcare (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), among others."Browse 403 market data Tables and 57 Figures spread through 431 Pages and in-depth TOC on "Patient Monitoring Devices Market by Product (Cardiac monitoring devices, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, blood pressure monitors, ECG, ICP, weight Monitoring), User, Customer Unmet Needs- Global Forecast to 2029

The healthcare landscape is rapidly evolving with the integration of advanced patient monitoring devices, enabling clinicians to track patient health in real-time and improve outcomes. The global patient monitoring devices market is projected to reach USD 71.1 billion by 2029, up from USD 48.5 billion in 2024, growing at a CAGR of 8.0%. This growth is fueled by technological advancements, rising chronic disease prevalence, and an increasing focus on remote and continuous patient monitoring.

Market Overview

The patient monitoring devices market is segmented by product, user, and region:

• By Product: Blood Glucose Monitoring Systems (self-monitoring, continuous, wearable), Cardiac Monitoring Devices, Multi-Parameter Monitors, Respiratory Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Weight Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Temperature Monitoring Devices, and more
• By User: Hospitals, Clinics, Home Healthcare, Ambulatory Care
• By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Download PDF Brochure @

Key Market Trends

1. Blood Glucose Monitoring Systems Driving Growth

Among product categories, blood glucose monitoring systems are expected to register a significant growth rate from 2024 to 2029. Key drivers include:

• Rising prevalence of Type 2 diabetes due to obesity, sedentary lifestyles, and unhealthy diets
• Increasing adoption of continuous glucose monitoring (CGM) and wearable devices
• Early detection of hyperglycemia and hypoglycemia, enabling timely intervention
• Growing patient preference for home-based monitoring for convenience and safety

Blood glucose monitoring devices not only empower patients to manage their health but also help clinicians personalize treatment plans and prevent complications.

2. Wireless & Wearable Technologies Enhancing Patient Care

The market is increasingly seeing a shift toward wireless monitoring solutions and biosensors, which provide real-time data without tethering patients to bedside equipment. Benefits include:

• Continuous monitoring of vital signs such as heart rate, oxygen saturation, and blood pressure
• Improved patient mobility and comfort
• Integration with mobile apps and cloud platforms for remote healthcare delivery
• Timely alerts for critical conditions, enhancing preventive care

These innovations are particularly valuable for chronic disease management, elderly care, and post-operative monitoring.

3. North America Leading the Market

In 2023, North America dominated the patient monitoring market due to:

• High prevalence of chronic diseases like diabetes, heart disease, and respiratory disorders
• Emphasis on preventive healthcare and early intervention
• Well-established healthcare infrastructure and strong investments in advanced monitoring technologies
• Government initiatives and public-private partnerships promoting remote and continuous patient monitoring

The region's leadership in technological adoption and healthcare innovation continues to drive market expansion.

Market Drivers

Several factors are propelling the patient monitoring devices market:

• Increasing Chronic Disease Prevalence: Rising cases of diabetes, cardiovascular, and respiratory illnesses
• Technological Advancements: Integration of AI, IoT, and cloud-based analytics for predictive monitoring
• Growing Geriatric Population: Higher demand for continuous monitoring solutions in elderly care
• Rising Public-Private Investments: Funding to enhance clinical research and healthcare infrastructure
• Remote Patient Monitoring: Expansion of telehealth and home care services

Key Players

Prominent companies driving innovations in patient monitoring include:

• Medtronic (Ireland)
• Nihon Kohden Corporation (Japan)
• Mindray Medical International Ltd. (China)
• GE Healthcare (US)
• Abbott Laboratories (US)
• Boston Scientific Corporation (US)

These players focus on developing wireless, wearable, and AI-integrated monitoring devices, expanding market reach, and addressing unmet clinical needs globally.

Market Outlook

The patient monitoring devices market is set for sustained growth, fueled by emerging technologies, increasing chronic disease burden, and the rise of home-based care solutions. Continuous innovations in wireless monitoring, wearable biosensors, and AI-powered analytics are enabling proactive healthcare, improving patient outcomes, and transforming traditional monitoring paradigms.

MENAFN05112025003238003268ID1110302154